Search company, investor...

Jiumingzhu

his999.com

Stage

Series A - II | Alive

Total Raised

$7.61M

Last Raised

$4.54M | 5 yrs ago

About Jiumingzhu

Jiumingzhu (九明珠) is a healthcare information software developer and service provider that develops healthcare cloud platform for micro, small and medium-sized medical institutions.

Headquarters Location

Shenzhen, Guangdong,

China

Missing: Jiumingzhu's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Jiumingzhu's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Jiumingzhu

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Jiumingzhu is included in 1 Expert Collection, including Digital Health.

D

Digital Health

13,587 items

Jiumingzhu Frequently Asked Questions (FAQ)

  • Where is Jiumingzhu's headquarters?

    Jiumingzhu's headquarters is located at Shenzhen.

  • What is Jiumingzhu's latest funding round?

    Jiumingzhu's latest funding round is Series A - II.

  • How much did Jiumingzhu raise?

    Jiumingzhu raised a total of $7.61M.

  • Who are the investors of Jiumingzhu?

    Investors of Jiumingzhu include LingDu Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.